本页面由Tiger Trade Technology Pte. Ltd.提供服务

百济神州

284.05
-1.2500-0.44%
盘后284.050.00000.00%19:54 EDT
成交量:22.91万
成交额:6,520.07万
市值:315.30亿
市盈率:545.83
高:288.46
开:285.31
低:283.04
收:285.30
52周最高:385.22
52周最低:196.45
股本:1.11亿
流通股本:8,557.73万
量比:0.96
换手率:0.27%
股息:- -
股息率:- -
每股收益(TTM):0.5204
每股收益(LYR):2.47
净资产收益率:7.46%
总资产收益率:3.96%
市净率:7.23
市盈率(LYR):115.00

数据加载中...

2026/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/26

重要事件披露

Form 8-K - Current report
2026/02/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/19

重要事件披露

Form 8-K - Current report
2025/12/18

重要事件披露

Form 8-K - Current report
2025/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/19

重要事件披露

Form 8-K - Current report
2025/11/17

关联方拟减持公告

Form 144 | BeOne Medicines Ltd. 高管 Xiaobin Wu 拟减持3991股,总价约151.83万美元
2025/11/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/06

重要事件披露

Form 8-K - Current report
2025/10/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/16

关联方拟减持公告

Form 144 | BeOne Medicines Ltd.高管 PAN-OYLER FOUNDATION 拟减持1204股,总价约40万美元
2025/09/16

关联方拟减持公告

Form 144 | BeOne Medicines高管John V Oyler拟减持27803股,总价约923.81万美元
2025/09/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities